Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
FGF4 (Fibroblast growth factor 4)
i
Other names:
FGF4, Fibroblast Growth Factor 4, Transforming Protein KS3, Human Stomach Cancer, Transforming Factor From FGF-Related Oncogene, Heparin Secretory Transforming Protein 1, Heparin-Binding Growth Factor 4, HBGF-4, HSTF-1, FGF-4, HST-1, Fibroblast Growth Factor 4 Splice Isoform, Heparin Secretory-Transforming Protein 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2249
Associations
(9)
News
Trials
VERI cancer hierarchy
Reset Filters
FGF4 amplification + ER positive
HER2 Negative Breast Cancer
FGF4 amplification + ER positive
HER2 Negative Breast Cancer
palbociclib + PF-05212384
Sensitive: C3 – Early Trials
palbociclib + PF-05212384
Sensitive
:
C3
palbociclib + PF-05212384
Sensitive: C3 – Early Trials
palbociclib + PF-05212384
Sensitive
:
C3
FGF4 amplification
Hepatocellular Cancer
FGF4 amplification
Hepatocellular Cancer
sorafenib
Sensitive: C3 – Early Trials
sorafenib
Sensitive
:
C3
sorafenib
Sensitive: C3 – Early Trials
sorafenib
Sensitive
:
C3
FGF4 mutation
Urothelial Cancer
FGF4 mutation
Urothelial Cancer
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
abemaciclib
Sensitive: D – Preclinical
abemaciclib
Sensitive
:
D
abemaciclib
Sensitive: D – Preclinical
abemaciclib
Sensitive
:
D
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
INNO-406
Sensitive: D – Preclinical
INNO-406
Sensitive
:
D
INNO-406
Sensitive: D – Preclinical
INNO-406
Sensitive
:
D
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
erdafitinib
Sensitive: D – Preclinical
erdafitinib
Sensitive
:
D
erdafitinib
Sensitive: D – Preclinical
erdafitinib
Sensitive
:
D
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
tipifarnib
Sensitive: D – Preclinical
tipifarnib
Sensitive
:
D
tipifarnib
Sensitive: D – Preclinical
tipifarnib
Sensitive
:
D
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
MK-2206
Sensitive: D – Preclinical
MK-2206
Sensitive
:
D
MK-2206
Sensitive: D – Preclinical
MK-2206
Sensitive
:
D
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
FGF4 amplification + HRAS Q61R + TP53 672+2T>G
Prostate Cancer
APR-246
Sensitive: D – Preclinical
APR-246
Sensitive
:
D
APR-246
Sensitive: D – Preclinical
APR-246
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.